Investigators assessed the addition of pulse-oximetry to self-reported improvements during hypoglossal nerve stimulation home titration for patients with moderate to severe obstructive sleep apnea.
The eXciteOSA device is used while the individual is awake and provides electrical muscle stimulation through a mouthpiece that sits around the tongue.
There may be increased hospitalization risk from influenza infection in patients with obstructive sleep apnea who do not use continuous positive airway pressure.
Researchers reviewed COVID-19 literature to determine the relationship between obstructive sleep apnea (OSA) and adverse COVID-19 outcomes.
Investigators assessed the incidence of obstructive sleep apnea in patients with HIV and the comorbidities associated with increased incidence.
A review of relevant literature looked at the relationship between obstructive sleep apnea and adverse COVID-19 outcomes.
Researchers analyzed autopsy brain tissue from confirmed obstructive sleep apnea cases for amyloid beta and tau, hallmark proteins of Alzheimer disease.
Patients with sleep apnea who received positive airway pressure therapy did not exhibit reduced cardiovascular risk compared with patients who received usual care.
Researchers examined patients with central sleep apnea after 5 years of treatment with transvenous phrenic nerve stimulation therapy.
Continuous positive airway pressure treatment for obstructive sleep apnea optimally used at night reduces resting heart rate during the day.
